| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ORIGINAL ARTICLES |
From the Division of Surgical Oncology, Department of Surgery, James Graham Brown Cancer Center (KMM, MJE, SLW, and VV), and Department of Mathematics (PBC), University of Louisville, Louisville, Kentucky; University of South Florida, Moffitt Cancer Center, Tampa, Florida (DSR); University of Texas M.D. Anderson Cancer Center, Houston, Texas (MIR, JEG); Department of Surgery, University of Vermont, Burlington, Vermont (DNK); and LDS Hospital, Salt Lake City, Utah (RDN).
Correspondence: Address correspondence and reprint requests to: Dr. Kelly M. McMasters, University of Louisville-Brown Cancer Center, 529 S. Jackson St., Louisville, KY 40202; Fax: 502-852-8031; Email: kelly.mcmasters{at}nortonhealthcare.org
Background: Sentinel lymph node (SLN) biopsy has become a standard method of staging patients with cutaneous melanoma. Sentinel lymph node biopsy usually is performed by intradermal injection of a vital blue dye (isosulfan blue) plus radioactive colloid (technetium sulfur colloid) around the site of the tumor. Intraoperative gamma probe detection has been shown to improve the rate of SLN identification compared to the use of blue dye alone. However, multiple sentinel nodes often are detected using the gamma probe. It is not clear whether these additional lymph nodes represent true sentinel nodes, or second-echelon lymph nodes that have received radiocolloid particles that have passed through the true sentinel node. This analysis was performed to determine the frequency with which these less radioactive lymph nodes contain metastatic disease when the most radioactive, or "hottest," node does not.
Materials and Methods: In the Sunbelt Melanoma Trial, 1184 patients with cutaneous melanoma of Breslow thickness 1.0 mm or more had sentinel lymph nodes identified. Sentinel lymph node biopsy was performed by injection of technetium sulfur colloid plus isosulfan blue dye in 99% of cases. Intraoperative determination of the degree of radioactivity of sentinel nodes (ex vivo) was measured, as well as the degree of blue dye staining.
Results: Sentinel nodes were identified in 1373 nodal basins in 1184 patients. A total of 288 of 1184 patients (24.3%) were found to have sentinel node metastases detected by histology or immunohistochemistry. Nodal metastases were detected in 306 nodal basins in these 288 patients. There were 175 nodal basins from 170 patients in which at least one positive sentinel node was found and more than one sentinel node was harvested. Blue dye staining was found in 86.3% of the histologically positive sentinel nodes and 66.4% of the negative sentinel nodes. In 40 of 306 positive nodal basins (13.1%), the most radioactive sentinel node was negative for tumor when another, less radioactive, sentinel node was positive for tumor. In 20 of 40 cases (50%), the less radioactive positive sentinel node contained 50% or less of the radioactive count of the hottest lymph node. The cervical lymph node basin was associated with an increased likelihood of finding a positive sentinel node other than the hottest node.
Conclusions: If only the most radioactive sentinel node in each basin had been removed, 13.1% of the nodal basins with positive sentinel nodes would have been missed. It is recommended that all blue lymph nodes and all nodes that measure 10% or higher of the ex vivo radioactive count of the hottest sentinel node should be harvested for optimal detection of nodal metastases.
Key Words: Melanoma • Sentinel lymph node • Lymph node dissection • Lymphoscintigraphy • Lymphatic mapping
This article has been cited by other articles:
 |
|
 |
|
  R. Riber-Hansen, P. Sjoegren, S. J. Hamilton-Dutoit, and T. Steiniche Extensive Pathological Analysis of Selected Melanoma Sentinel Lymph Nodes: High Metastasis Detection Rates at Reduced Workload Ann. Surg. Oncol., May 1, 2008; 15(5): 1492 - 1501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. Dalal, A. Patel, M. S. Brady, D. P. Jaques, and D. G. Coit Patterns of First-Recurrence and Post-recurrence Survival in Patients with Primary Cutaneous Melanoma After Sentinel Lymph Node Biopsy Ann. Surg. Oncol., June 1, 2007; 14(6): 1934 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. P. Parungo, D. I. Soybel, Y. L. Colson, S.-W. Kim, S. Ohnishi, A. M. DeGrand, R. G. Laurence, E. G. Soltesz, F. Y. Chen, L. H. Cohn, et al. Lymphatic Drainage of the Peritoneal Space: A Pattern Dependent on Bowel Lymphatics: Resident/Fellow Essay Award Winner for the Best Clinical Research Paper Basic Science and Special Investigator Award Winners Ann. Surg. Oncol., February 1, 2007; 14(2): 286 - 298. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications CA Cancer J Clin, September 1, 2006; 56(5): 292 - 309. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R. Scoggins, M. I. Ross, D. S. Reintgen, R. D. Noyes, J. S. Goydos, P. D. Beitsch, M. M. Urist, S. Ariyan, B. S. Davidson, J. J. Sussman, et al. Prospective Multi-Institutional Study of Reverse Transcriptase Polymerase Chain Reaction for Molecular Staging of Melanoma J. Clin. Oncol., June 20, 2006; 24(18): 2849 - 2857. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. R. Berk, D. L. Johnson, A. Uzieblo, M. Kiernan, and S. M. Swetter Sentinel Lymph Node Biopsy for Cutaneous Melanoma: The Stanford Experience, 1997-2004 Arch Dermatol, August 1, 2005; 141(8): 1016 - 1022. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. L. Wong, M. W. Kattan, K. M. McMasters, and D. G. Coit A Nomogram That Predicts the Presence of Sentinel Node Metastasis in Melanoma With Better Discrimination Than the American Joint Committee on Cancer Staging System Ann. Surg. Oncol., April 1, 2005; 12(4): 282 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. P. Parungo, S. Ohnishi, S.-W. Kim, S. Kim, R. G. Laurence, E. G. Soltesz, F. Y. Chen, Y. L. Colson, L. H. Cohn, M. G. Bawendi, et al. Intraoperative identification of esophageal sentinel lymph nodes with near-infrared fluorescence imaging J. Thorac. Cardiovasc. Surg., April 1, 2005; 129(4): 844 - 850. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. B. Roaten, N. Pearlman, R. Gonzalez, R. Gonzalez, and M. D. McCarter Identifying Risk Factors for Complications Following Sentinel Lymph Node Biopsy for Melanoma Arch Surg, January 1, 2005; 140(1): 85 - 89. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. B. Stitzenberg, P. A. Groben, S. L. Stern, N. E. Thomas, T. A. Hensing, L. B. Sansbury, and D. W. Ollila Indications for Lymphatic Mapping and Sentinel Lymphadenectomy in Patients with Thin Melanoma (Breslow Thickness <=1.0 mm) Ann. Surg. Oncol., October 1, 2004; 11(10): 900 - 906. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chao, R. C. G. Martin II, M. I. Ross, D. S. Reintgen, M. J. Edwards, R. D. Noyes, L. J. Hagendoorn, A. J. Stromberg, and K. M. McMasters Correlation Between Prognostic Factors and Increasing Age in Melanoma Ann. Surg. Oncol., March 1, 2004; 11(3): 259 - 264. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. R. Wrightson, S. L. Wong, M. J. Edwards, C. Chao, D. S. Reintgen, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and K. M. McMasters Complications Associated With Sentinel Lymph Node Biopsy for Melanoma Ann. Surg. Oncol., July 1, 2003; 10(6): 676 - 680. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Lardinois, T. Brack, A. Gaspert, T. Spahr, D. Schneiter, H.C. Steinert, and W. Weder Bronchoscopic radioisotope injection for sentinel lymph-node mapping in potentially resectable non-small-cell lung cancer Eur. J. Cardiothorac. Surg., May 1, 2003; 23(5): 824 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R.J.C.L.M. Vuylsteke, P.A.M. van Leeuwen, M.G. S. Muller, H.A. Gietema, D.R. Kragt, and S. Meijer Clinical Outcome of Stage I/II Melanoma Patients After Selective Sentinel Lymph Node Dissection: Long-Term Follow-Up Results J. Clin. Oncol., March 15, 2003; 21(6): 1057 - 1065. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Chao, S. L. Wong, M. J. Edwards, M. I. Ross, D. S. Reintgen, R. D. Noyes, W. K. Stadelmann, E. Lentsch, and K. M. McMasters Sentinel Lymph Node Biopsy for Head and Neck Melanomas Ann. Surg. Oncol., January 1, 2003; 10(1): 21 - 26. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. S. Tyler and H. F. Seigler High Isotope Counts and Sentinel Node Positivity in Patients With Melanoma--Invited Critique Arch Surg, January 1, 2003; 138(1): 67 - 67. [Full Text] [PDF]
|
|
|
|
|
|
G. W. Carlson, D. R. Murray, V. Thourani, A. Hestley, and C. Cohen The Definition of the Sentinel Lymph Node in Melanoma Based on Radioactive Counts Ann. Surg. Oncol., November 1, 2002; 9(9): 929 - 933. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Nomori, H. Horio, T. Naruke, H. Orikasa, K. Yamazaki, and K. Suemasu Use of technetium-99m tin colloid for sentinel lymph node identification in non-small cell lung cancer J. Thorac. Cardiovasc. Surg., September 1, 2002; 124(3): 486 - 492. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Mariani, M. Gipponi, L. Moresco, G. Villa, M. Bartolomei, G. Mazzarol, M. C. Bagnara, A. Romanini, F. Cafiero, G. Paganelli, et al. Radioguided Sentinel Lymph Node Biopsy in Malignant Cutaneous Melanoma* J. Nucl. Med., June 1, 2002; 43(6): 811 - 827. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. M. McMasters, S. L. Wong, and C. Chao Comment on the article "Highest Isotope Count Does Not Predict Sentinel Node Positivity in All Breast Cancer Patients," by Martin et al., August 2001, Annals of Surgical Oncology Ann. Surg. Oncol., April 1, 2002; 9(3): 317 - 318. [Full Text] [PDF]
|
|
|
|
|
|
K. M. McMasters, S. L. Wong, M. J. Edwards, C. Chao, M. I. Ross, R. D. Noyes, V. Viar, P. B. Cerrito, and D. S. Reintgen Frequency of Nonsentinel Lymph Node Metastasis in Melanoma Ann. Surg. Oncol., March 1, 2002; 9(2): 137 - 141. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. G. Patel, D. G. Coit, A. R. Shaha, M. S. Brady, J. O. Boyle, B. Singh, J. P. Shah, and D. H. Kraus Sentinel Lymph Node Biopsy for Cutaneous Head and Neck Melanomas Arch Otolaryngol Head Neck Surg, March 1, 2002; 128(3): 285 - 291. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. G. Coit The ""True"" Sentinel Lymph Node: In Search of an Operational Definition of a Biological Phenomenon Ann. Surg. Oncol., April 1, 2001; 8(3): 187 - 189. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
